Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan. - Genetic Engineering News

AUSTIN, Texas, May 22, 2012 /PRNewswire/ -- Prodigy Generics, a division of Prodigy Health Supplier Corporation (PHS), has launched injectable irinotecan. Irinotecan is the generic equivalent of the branded drug Camptosar by Pfizer. Prodigy ...

Sagent Pharma launches irinotecan Hcl injection in single dose vials - pharmabiz.com

Sagent Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, has launched irinotecan injection, the generic form of the chemotherapy drug Camptosar, in two latex free ...

Sagent Pharmaceuticals Announces Launch of Irinotecan Hydrochloride Injection in Single Dose Vials - Yahoo Finance

SCHAUMBURG, Ill., May 17, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT - News) today announced the launch of Irinotecan Injection, the generic form of the chemotherapy drug Camptosar(R), in two latex free, preservative free ...

Alchemia Limited : Open Briefing - 4-traders (press release)

Alchemia Limited (ACL) yesterday announced that the independent Data Safety Monitoring Board (DSMB) for the Phase III clinical trial of its lead cancer drug, HA-Irinotecan, in second or third line metastatic colorectal cancer, has approved the continuation ...

GI Cancers: Promising Data Across the Board - Medscape News

[6] There will be an Intergroup report looking at the adjuvant chemotherapy comparators of conventional 5-fluorouracil leucovorin vs a much more complex dose-intense regime looking at irinotecan and 5-fluorouracil leucovorin, followed sequentially by ...

New cancer drugs held up by the NHS for nine years as rationing body accused of letting down patients - Daily Mail

The average delay for multiple drugs given the green light in 2005 was 8.7 years. They included treatments for bowel cancer (irinotecan and oxaliplatin) and cancer of the womb (topotecan and pacilitaxel). In 2006 NICE approved three Alzheimer’s drugs ...

Enzon and Hisun Announce Strategic Alliance for Enzon's Customized PEGylation Linker Technology and Licensing Agreement for PEG-SN38 in China - msnbc.com

It is a PEGylated conjugate of SN38, the active metabolite of the widely used anti-cancer drug irinotecan. PEG-SN38 offers therapeutic advantages over unmodified SN38, including increased solubility, higher exposure and tumor accumulation ...

Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction - msnbc.com

Irinotecan (Campotsar), Ixabepilone (Ixempra), KW 2450, Lapatinib (Tykerb), Letrozole (Femara), Leuprorelin depot (Carcinil), Litronesib, Lobaplatin, MEDI 573, MetMAb, Mitoxantrone (Novantrone), Motesanib, MVA-BN-HER2 AutoVac, N-Acetyl GM3 ...

Other News To Note - TMCnet

Terms were not disclosed. • Sagent Pharmaceuticals Inc., of Schaumburg, Ill., said it launched irinotecan injection, a generic form of Camptosar, New York-based Pfizer Inc.'s chemotherapy drug. The generic is available in two latex-free ...

Major Milestone Reached in Salient Pharmaceuticals' Phase II Trial - Houston Chronicle

Launched in February 2009, the Phase II trial is studying the ability of Salient’s product to prevent and/or treat diarrhea in metastatic colorectal cancer patients receiving irinotecan®. It is being supported by the National Cancer Institute’s ...